The CEO of Novo Nordisk defended the high cost of Ozempic and Wegovy in the U.S., saying the blockbuster drugs are ultimately saving taxpayers money on obesity-related costs.  

Please Like, Comment and Follow 'The Afternoon Drive with Philip Teresi & E. Curtis Johnson' on all platforms:  

---   

The Afternoon Drive with Philip Teresi & E. Curtis Johnson is available on the KMJNOW app, Apple Podcasts, Spotify, YouTube or wherever else you listen to podcasts.   

-- 

The Afternoon Drive with Philip Teresi & E. Curtis Johnson  

Weekdays 2-6 PM Pacific on News/Talk 580 AM & 105.9 FM KMJ  

 | Website  | Facebook | Instagram | X | Podcast | Amazon |  

- 

Everything KMJ  

KMJNOW App | Podcasts | Facebook | X | Instagram   

See omnystudio.com/listener for privacy information.